Circulating human eosinophils share a similar transcriptional profile in asthma and other hypereosinophilic disorders

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Barnig, Cindy ^a,b,c   Alsaleh, Ghada ^a,c   Jung, Nicolas ^a   Dembélé, Doulaye ^a   Paul, Nicodème ^a,c   Poirot, Anh ^b,c   Uring Lambert, Béatrice ^b,c   Georgel, Philippe ^a,c   De Blay, Fréderic ^b,c   Bahram, Seiamak ^a,b,c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL CIVIL   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TRANSCRIPTOME;

ADULT; AGED; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; ASTHMA; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; IMMUNOMODULATION; INNATE IMMUNITY; LUNG ASPERGILLOSIS; MALE; PARASITOSIS; TRANSCRIPTOMICS; BLOOD; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HYPEREOSINOPHILIC SYNDROME; METABOLISM; MIDDLE AGED; PROCEDURES;

ADULT; AGED; ASTHMA; EOSINOPHILS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPEREOSINOPHILIC SYNDROME; MALE; MIDDLE AGED; TRANSCRIPTOME;

EID: 84950327271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141740     Document Type: Article

References (42)

1. Rothenberg ME, Hogan SP. The eosinophil. Annual Review of Immunology 2006: 24: 147-174. PMID: 16551246
2. Hamann KJ, Barker RL, Loegering DA, Gleich GJ. Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. The Journal of parasitology 1987: 73(3): 523-529. PMID: 3598802
3. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. The New England Journal of Medicine 1990: 323(15): 1033-1039. PMID: 2215562
4. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000: 356(9248): 2144-2148. PMID: 11191542
5. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. The New England Journal of Medicine 2009: 360(10): 985-993. doi: 10.1056/NEJMoa0805435 PMID: 19264687
6. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 1998: 161(3): 1501-1509. PMID: 9686617
7. Fattouh R, Al-Garawi A, Fattouh M, Arias K, Walker TD, Goncharova S, et al. Eosinophils are dispensable for allergic remodeling and immunity in a model of house dust mite-induced airway disease. American Journal of Respiratory and Critical Care Medicine 2011: 183(2): 179-188. doi: 10.1164/rccm. 200905-0736OC PMID: 20732990
8. Valent P, Gleich GJ, Reiter A, Roufosse F, Weller PF, Hellmann A, et al. Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Review of Hematology 2012: 5(2): 157-176. doi: 10.1586/ehm.11.81 PMID: 22475285
9. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nature Reviews Drug Discovery 2013: 12(2): 117-129. doi: 10.1038/nrd3838 PMID: 23334207
10. Isobe Y, Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, et al. Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17, 18-dihydroxyeicosapentaenoic acid. The Journal of Biological Chemistry 2012: 287(13): 10525-10534. doi: 10.1074/jbc.M112.340612 PMID: 22275352
11. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, Locksley RM, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013: 153(2): 376-388. doi: 10.1016/j.cell.2013.02.053 PMID: 23582327
12. Esnault S, Kelly EA, Schwantes EA, Liu LY, Delain LP, Hauer JA, et al. Identification of genes expressed by human airway eosinophils after an in vivo allergen challenge. PloS one 2013: 8(7): e67560. doi: 10.1371/journal.pone.0067560 PMID: 23844029
13. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. The Journal of Allergy and Clinical Immunology 2012: 130(3): 607-612 e609. doi: 10.1016/j.jaci.2012.02.019 PMID: 22460074
14. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003: 19(2): 185-193. PMID: 12538238
15. Dembele D, Kastner P. Fold change rank ordering statistics: a new method for detecting differentially expressed genes. BMC Bioinformatics 2014: 15: 14. doi: 10.1186/1471-2105-15-14 PMID: 24423217
16. Bates ME, Liu LY, Esnault S, Stout BA, Fonkem E, Kung V, et al. Expression of interleukin-5- and granulocyte macrophage-colony-stimulating factor-responsive genes in blood and airway eosinophils. American Journal of Respiratory Cell and Molecular biology 2004: 30(5): 736-743. PMID: 14630612
17. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacological reviews 1999: 51(2): 213-340. PMID: 10353986
18. Temple R, Allen E, Fordham J, Phipps S, Schneider HC, Lindauer K, et al. Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. American Journal of Respiratory Cell and Molecular Biology 2001: 25(4): 425-433. PMID: 11694447
19. Wilson SS, Wiens ME, Smith JG. Antiviral mechanisms of human defensins. Journal of molecular biology 2013: 425(24): 4965-4980. doi: 10.1016/j.jmb.2013.09.038 PMID: 24095897
20. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respiratory research 2006: 7: 73. PMID: 16684353
21. Liang S, Wei X, Gong C, Wei J, Chen Z, Chen X, et al. Significant association between asthma risk and the GSTM1 and GSTT1 deletion polymorphisms: an updated meta-analysis of case-control studies. Respirology 2013: 18(5): 774-783. doi: 10.1111/resp.12097 PMID: 23600494
22. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009: 4(1): 44-57. doi: 10.1038/nprot.2008.211 PMID: 19131956
23. Munoz NM, Leff AR. Highly purified selective isolation of eosinophils from human peripheral blood by negative immunomagnetic selection. Nature Protocols 2006: 1(6): 2613-2620. PMID: 17406516
24. Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. The Journal of Allergy and Clinical Immunology 2015: 135(1): 187-197. doi: 10.1016/j. jaci.2014.08.043 PMID: 25441638
25. Sherrill JD, Kiran KC, Blanchard C, Stucke EM, Kemme KA, Collins MH, et al. Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes and Immunity 2014: 15(6): 361-369. doi: 10.1038/gene.2014.27 PMID: 24920534
26. Tsitsiou E, Williams AE, Moschos SA, Patel K, Rossios C, Jiang X, et al. Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. The Journal of Allergy and Clinical Immunology 2012: 129(1): 95-103. doi: 10.1016/j.jaci.2011.08.011 PMID: 21917308
27. Ogawa K, Hashida R, Miyagawa M, Kagaya S, Sugita Y, Matsumoto K, et al. Analysis of gene expression in peripheral blood eosinophils from patients with atopic dermatitis and in vitro cytokine-stimulated blood eosinophils. Clinical and Experimental Immunology 2003: 131(3): 436-445. PMID: 12605696
28. Johnsson M, Bove M, Bergquist H, Olsson M, Fornwall S, Hassel K, et al. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. Journal of Innate Immunity 2011: 3(6): 594-604. doi: 10.1159/000331326 PMID: 21921589
29. Ochkur SI, Jacobsen EA, Protheroe CA, Biechele TL, Pero RS, McGarry MP, et al. Coexpression of IL- 5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma. J Immunol 2007: 178(12): 7879-7889. PMID: 17548626
30. Jacobsen EA, Lesuer WE, Willetts L, Zellner KR, Mazzolini K, Antonios N, et al. Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice. Allergy 2014: 69(3): 315-327. doi: 10.1111/all.12321 PMID: 24266710
31. Flood-Page P, Menzies-Gow A, Phipps S, Ying S, Wangoo A, Ludwig MS, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. The Journal of Clinical Investigation 2003: 112(7): 1029-1036. PMID: 14523040
32. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. The New England Journal of Medicine 2009: 360(10): 973-984. doi: 10.1056/NEJMoa0808991 PMID: 19264686
33. Castro M, Mathur S, Hargreave F, Boulet LP, Xie F, Young J, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. American Journal of Respiratory and Critical Care Medicine 2011: 184(10): 1125-1132. doi: 10.1164/rccm.201103-0396OC PMID: 21852542
34. Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012: 380(9842): 651-659. doi: 10.1016/S0140-6736(12)60988-X PMID: 22901886
35. Bisgaard H. Leukotrienes and prostaglandins in asthma. Allergy 1984: 39(6): 413-420. PMID: 6208802
36. Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Letters 1992: 307(1): 97-101. PMID: 1639201
37. Sutherland DB, Fagarasan S. Gut reactions: Eosinophils add another string to their bow. Immunity 2014: 40(4): 455-457. doi: 10.1016/j.immuni.2014.04.003 PMID: 24745328
38. Hedhli N, Falcone DJ, Huang B, Cesarman-Maus G, Kraemer R, Zhai H, et al. The annexin A2/S100A10 system in health and disease: emerging paradigms. Journal of Biomedicine & Biotechnology 2012: 2012: 406273. doi: 10.1155/2012/406273 PMID: 23193360
39. Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014: 156(1-2): 20-44. doi: 10.1016/j.cell.2013.12.012 PMID: 24439368
40. Wu T, Angus CW, Yao XL, Logun C, Shelhamer JH. P11, a unique member of the S100 family of calcium- binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2. The Journal of Biological Chemistry 1997: 272(27): 17145-17153. PMID: 9202034
41. Du H, Schiavi S, Levine M, Mishra J, Heur M, Grabowski GA. Enzyme therapy for lysosomal acid lipase deficiency in the mouse. Human Molecular Genetics 2001: 10(16): 1639-1648. PMID: 11487567
42. Lian X, Yan C, Yang L, Xu Y, Du H. Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung. American Journal of Physiology Lung Cellular and Molecular Physiology 2004: 286(4): L801-807. PMID: 14644759